Want to see GMED full AI Analyst Report?
Total Valuation
Globus Medical has a market cap or net worth of $10.02B. The enterprise value is $10.37B.
Market Cap$10.02B
Enterprise Value$10.37B
Share Statistics
Globus Medical has 111,831,820 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding111,831,820
Owned by Insiders0.74%
Owned by Institutions0.84%
Financial Efficiency
Globus Medical’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.78%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)8.78%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee489.82K
Profits Per Employee89.64K
Employee Count6,000
Asset Turnover0.55
Inventory Turnover1.26
Valuation Ratios
The current PE Ratio of Globus Medical is 18.9. Globus Medical’s PEG ratio is 0.05.
PE Ratio18.9
PS Ratio4.02
PB Ratio2.58
Price to FCF20.04
Price to Operating Cash Flow11.10
PEG Ratio0.05
Income Statement
In the last 12 months, Globus Medical had revenue of 2.94B and earned 537.90M in profits. Earnings per share was 3.98.
Revenue2.94B
Gross Profit1.98B
Operating Income479.80M
Pretax Income609.90M
Net Income537.90M
EBITDA886.74M
Earnings Per Share (EPS)3.98
Cash Flow
In the last 12 months, operating cash flow was 910.39M and capital expenditures -159.80M, giving a free cash flow of 750.59M billion.
Operating Cash Flow910.39M
Free Cash Flow750.59M
Free Cash Flow per Share6.71
Dividends & Yields
Globus Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.73
52-Week Price Change29.85%
50-Day Moving Average79.10
200-Day Moving Average84.34
Relative Strength Index (RSI)44.53
Average Volume (3m)1.50M
Important Dates
Globus Medical upcoming earnings date is Nov 10, 2026, After Close (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateNov 10, 2026
Ex-Dividend Date―
Financial Position
Globus Medical as a current ratio of 4.26, with Debt / Equity ratio of 2.33%
Current Ratio4.26
Quick Ratio2.74
Debt to Market Cap<0.01
Net Debt to EBITDA-0.46
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Globus Medical has paid 72.00M in taxes.
Income Tax72.00M
Effective Tax Rate0.12
Enterprise Valuation
Globus Medical EV to EBITDA ratio is 12.85, with an EV/FCF ratio of 19.35.
EV to Sales3.88
EV to EBITDA12.85
EV to Free Cash Flow19.35
EV to Operating Cash Flow15.12
Balance Sheet
Globus Medical has $595.14M in cash and marketable securities with $111.19M in debt, giving a net cash position of $483.95M billion.
Cash & Marketable Securities$595.14M
Total Debt$111.19M
Net Cash$483.95M
Net Cash Per Share$4.33
Tangible Book Value Per Share$17.71
Margins
Gross margin is 68.55%, with operating margin of 16.33%, and net profit margin of 18.30%.
Gross Margin68.55%
Operating Margin16.33%
Pretax Margin20.75%
Net Profit Margin18.30%
EBITDA Margin30.17%
EBIT Margin20.75%
Analyst Forecast
The average price target for Globus Medical is $98.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$98.75
Price Target Upside18.83% Upside
Analyst ConsensusModerate Buy
Analyst Count13
Revenue Growth Forecast19.74%
EPS Growth Forecast51.10%